Association of a functional FAAH polymorphism with methamphetamine-induced symptoms and dependence in a Malaysian population

Pharmacogenomics

Volumn 14, Issue 5, 2013, Pages 505-514

  Sim, Maw Shin ^a   Hatim, Ahmad ^a   Reynolds, Gavin Paul ^b   Mohamed, Zahurin ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

fatty acid amide hydrolase; mania episodes; methamphetamine dependence; panic disorder; psychosis; single nucleotide polymorphism

Indexed keywords

FATTY ACID AMIDASE; METHAMPHETAMINE; PROLINE; THREONINE;

ADULT; ARTICLE; BAJAU; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; ETHNIC GROUP; FAAH GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; KADAZAN DUSUN; MAJOR CLINICAL STUDY; MALAY; MALAYSIA; MALE; MANIA; METHAMPHETAMINE DEPENDENCE; PANIC; PSYCHOSIS; STATISTICAL ANALYSIS; SYMPTOMATOLOGY;

ADULT; AMIDOHYDROLASES; AMPHETAMINE-RELATED DISORDERS; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHAMPHETAMINE; PANIC DISORDER; PHENOTYPE; POLYMORPHISM, GENETIC; PSYCHOSES, SUBSTANCE-INDUCED; SUBSTANCE-RELATED DISORDERS;

EID: 84875917552     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.13.25     Document Type: Article

References (30)

1. Volkow ND, Chang L, Wang Gj et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am. J. Psychiatry 158(12), 2015-2021 (2001 (Pubitemid 33104107)
2. Morita Y, Ujike H, Tanaka Y et al. A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia. Neurosci. Lett. 376(3), 182-187 (2005) (Pubitemid 40255306)
3. Chiang KP, Gerber AL, Sipe JC, Cravatt BF. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum. Mol. Genet. 13(18), 2113-2119 (2004 (Pubitemid 39377833)
4. Patricelli MP, Cravatt BF. Fatty acid amide hydrolase competitively degrades bioactive amides and esters through a nonconventional catalytic mechanism. Biochemistry 38(43), 14125-14130 (1999
5. McKinney MK, Cravatt BF. Structure and function of fatty acid amide hydrolase. Annu. Rev. Biochem. 74, 411-432 (2005 (Pubitemid 40995513)
6. Cravatt BF, Lichtman AH. The endogenous cannabinoid system and its role in nociceptive behavior. J. Neurobiol. 61(1), 149-160 (2004 (Pubitemid 39287775)
7. Cravatt BF, Demarest K, Patricelli MP et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl Acad. Sci. USA 98(16), 9371-9376 (2001 (Pubitemid 32743923)
8. Boger DL, Sato H, Lerner AE et al. Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. Proc. Natl Acad. Sci. USA 97(10), 5044-5049 (2000 (Pubitemid 30313668)
9. Lichtman AH, Leung D, Shelton CC et al. Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity. J. Pharmacol. Exp. Ther. 311(2), 441-448 (2004 (Pubitemid 39391527)
10. Jayamanne A, Greenwood R, Mitchell VA, Aslan S, Piomelli D, Vaughan CW. Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models. Br. J. Pharmacol. 147(3), 281-288 (2006 (Pubitemid 43214685)
11. Sipe JC. The brain endogenous cannabinoid sysem: a role in reward/craving of addiction? Med. Hypotheses Res. 1, 1-10 (2004
12. Flanagan JM, Gerber AL, Cadet JL, Beutler E, Sipe JC. The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction. Hum. Genet. 120(4), 581-588 (2006 (Pubitemid 44669791)
13. Sipe JC, Chiang K, Gerber AL, Beutler E, Cravatt BF. A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proc. Natl Acad. Sci. USA 99(12), 8394-8399 (2002 (Pubitemid 34651063)
14. Haughey HM, Marshall E, Schacht JP, Louis A, Hutchison KE. Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. Addiction 103(10), 1678-1686 (2008
15. Schacht JP, Selling RE, Hutchison KE. Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysis. Psychopharmacology (Berl.) 203(3), 511-517 (2009
16. Filbey FM, Schacht JP, Myers US, Chavez RS, Hutchison KE. Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues. Neuropsychopharmacology 35(4), 967-975 (2010
17. Proudnikov D, Kroslak T, Sipe Jc et al. Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1. Pharmacogenomics J. 10(3), 232-242 (2010
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th Edition). American Psychiatric Press, Washington, DC, USA (1994
19. Sim MS, Mohamed Z, Hatim A, Rajagopal VL, Habil MH. Association of brain-derived neurotrophic factor (Val66Met) genetic polymorphism with methamphetamine dependence in a Malaysian population. Brain Res. 1357, 91-96 (2010
20. Sheehan DV, Lecrubier Y, Sheehan Kh et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59(Suppl. 20), 22-33; quiz 34-57 (1998 (Pubitemid 29001829)
21. Gordon D, Finch SJ, Nothnagel M, Ott J. Power and sample size calculations for case-control genetic association tests when errors are present: application to single nucleotide polymorphisms. Hum. Hered. 54(1), 22-33 (2002 (Pubitemid 35404246)
22. Gordon D, Levenstien MA, Finch SJ, Ott J. Errors and linkage disequilibrium interact multiplicatively when computing sample sizes for genetic case-control association studies. Pac. Symp. Biocomput. 490-501 (2003
23. Agrawal A, Lynskey MT. Candidate genes for cannabis use disorders: findings, challenges and directions. Addiction 104(4), 518-532 (2009
24. Hatin WI, Nur-Shafawati AR, Zahri Mk et al. Population genetic structure of peninsular Malaysia Malay sub-ethnic groups. PLoS ONE 6(4), e18312 (2011
25. Hock SS. Chinese migration. In: The Population of Malaysia. ISEAS Publishing, Pasir Panjang, Singapore (2007
26. Zeng J, Li J, Huang G. 385 C/A polymorphism of the fatty acid amide hydrolase gene is associated with metabolic syndrome in the Chinese Han population. Arch. Med. Sci. 7(3), 423-427 (2011
27. Camilleri M, Carlson P, McKinzie S et al. Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation. Am. J. Physiol. Gastrointest. Liver Physiol. 294(1), G13-G19 (2008
28. United Nations Information Service, UNIS: Launch of 2005 World Drug Report. www.unis.unvienna.org/unis/en/pressconf/2005/pb20050629.html2005
29. United Nations Office on Drugs and Crime, UNODC: World Drug Report 2011. www.unodc.org/unodc/en/dataandanalysis/WDR2011.html
30. National Anti-Drug Agency: January - October 2010 Drug Report. Kuala Lumpur, Malaysia: Ministry of Home Affairs. www.adk.gov.my/html/laporandadah/ Oktober%202010.pdf